₹2038.007.500.37%(1D)
Performance Stats for Glenmark Pharmaceuticals
Day Range
Low: ₹2021.80
High: ₹2046.90
52 Week Range
Low: ₹1275.50
High: ₹2284.80
Open Price
2028.90Previous Close
2030.50Volume
71590.00Open Price
2028.90Previous Close
2030.50Volume
71590.00Fundamentals of Glenmark Pharmaceuticals
ROCE
8.94%
EPS
₹52.57
Dividend Yield
0.16%
P/E Ratio
26.99
P/B Ratio
1.77
Debt to Equity
0.03
Current Ratio
1.25
Sales Growth
-16.79%
Profit Growth
-99.66%
EBIT Growth
-98.85%
Financials of Glenmark Pharmaceuticals
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Glenmark Pharmaceuticals
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development,...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Alembic Pharma | ₹777.6 1.01% |
| Aurobindo Pharma | ₹1195.5 0.92% |
| Cipla | ₹1343.9 0.92% |
| Ipca Laboratories | ₹1500 0.33% |
Most Viewed Stocks
Open Interest (OI)
Glenmark Pharmaceuticals Options
| Price | OI | Volume |
Events Related to Glenmark Pharmaceuticals
Board Meeting
Jan 30, 2026
Board Meeting
Nov 14, 2025
Dividend
Oct 3, 2025
Board Meeting
Sep 26, 2025
AGM
Sep 26, 2025
News About Glenmark Pharmaceuticals
Glenmark Q3 profit rises 16% on strong India, US performance
Jan 30, 2026
Q3 Results Today: Bajaj Auto, NTPC, Nestle India, Meesho Among Over 150 Companies To Declare Earnings On Jan. 30
Jan 30, 2026
US attacks Venezuela: 9 listed Indian companies that could see an impact
Jan 5, 2026
Stocks in news: BEML, IndiGo, Jindal Steel, ITC Hotels, Glenmark Pharma
Dec 12, 2025
Fresh bullish signals emerge for December derivatives trades
Dec 1, 2025
